γδ T cells at the interface of innate and adaptive immunity in cancer
Journal for ImmunoTherapy of Cancer · 2026-03 · 14 (3) · e013668
DOI: 10.1136/jitc-2025-013668 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 23.03.2026. Verfasst von Arnau Solé Casaramona und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology Immunology and Allergology, Inselspital University Hospital, University of Bern, Bern, Switzerland arnau.sole@unibe.ch. Hauptthemen laut MEDLINE: Immunity, Innate, Adaptive Immunity, Neoplasms, Receptors, Antigen, T-Cell, gamma-delta. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.
Abstract (Originalsprache)
γδ T cells are unconventional lymphocytes that bridge innate and adaptive immunity by combining recognition of stress-induced ligands independently of classical major histocompatibility complex molecules with the capacity to undergo clonal expansion and long-term adaptation. Their unusual ability to detect malignant transformation using semi-invariant T-cell receptors, butyrophilin recognition and natural killer-like receptors positions them as powerful effector cells in tumors that evade classical immune escape mechanisms. Furthermore, distinct γδ subsets have distinct phenotyping and specific tissue-residencies, which could be leveraged to modulate immunological responses. We evaluate engineered therapies and different experimental platforms for studying γδ T cell biology. We conclude that next-generation cancer treatments should strategically integrate γδ T cells into synthetic immunology, individualized modeling, and combinatorial regimes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology Immunology and Allergology, Inselspital University Hospital, University of Bern, Bern, Switzerland arnau.sole@unibe.ch.
- Department for BioMedical Research, University of Bern, Bern, Switzerland.
- Graduate School for Cellular and Biomedical Sciences (GCB), University of Bern, Bern, Switzerland.
- Department of Rheumatology Immunology and Allergology, Inselspital University Hospital, University of Bern, Bern, Switzerland.
- Nuffield Department of Medicine, The Henry Welcome Building for Molecular Physiology, The Jenner Institute, University of Oxford, Oxford, England, UK.
- Center for Molecular Imaging, Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Förderung
- NCI NIH HHS
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Zitieren
APA
Solé Casaramona, A., Bachmann, M. F., Sevick-Muraca, E., & O Mohsen, M. (2026). γδ T cells at the interface of innate and adaptive immunity in cancer. Journal for ImmunoTherapy of Cancer, 14(3), e013668. https://doi.org/10.1136/jitc-2025-013668
Vancouver
Solé Casaramona A, Bachmann MF, Sevick-Muraca E, O Mohsen M. γδ T cells at the interface of innate and adaptive immunity in cancer. Journal for ImmunoTherapy of Cancer. 2026;14(3):e013668. doi:10.1136/jitc-2025-013668
BibTeX
@article{SolCasaramona2026,
author = {Solé Casaramona, Arnau and Bachmann, Martin F and Sevick-Muraca, Eva and O Mohsen, Mona},
title = {γδ T cells at the interface of innate and adaptive immunity in cancer},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
volume = {14},
number = {3},
pages = {e013668},
doi = {10.1136/jitc-2025-013668}
}
EUVIMED